President Joe Biden has issued an executive order aimed at implementing stricter regulations on U.S. investment in high-tech Chinese companies. These restrictions will primarily target private equity and venture capital firms and focus on Chinese companies specializing in advanced technologies with military applications, such as quantum computing, artificial intelligence, and … [Read more...] about New Restrictions on U.S. Investment in Chinese High-Tech Companies
Investment
NFL Legend Tom Brady Becomes Minority Owner of Birmingham Soccer Team
BIRMINGHAM, England - Tom Brady, the renowned NFL quarterback and seven-time Super Bowl champion, has recently become a minority owner of Birmingham, an English second-tier soccer team. Partnering with the club's holding company, Knighthead Capital Management, Brady has assumed the role of chairman on a new advisory board. With his vast experience and proven track record in … [Read more...] about NFL Legend Tom Brady Becomes Minority Owner of Birmingham Soccer Team
Macquarie Group’s Q1 Earnings Drop
Shares of Macquarie Group, Australia's largest investment bank and asset managers, experienced a downward trend after the company reported "substantially down" earnings for the first quarter of fiscal year 2024. This news comes as a disappointment to some analysts who had higher expectations. The stock price fell by 4.3% to $175.07 Australian dollars (US$118.33), reaching a low … [Read more...] about Macquarie Group’s Q1 Earnings Drop
The Impasse over Carbon Emissions: A Boost for Clean-Tech Companies
China and the U.S. find themselves in a deadlock regarding carbon emissions after a meeting between U.S. climate envoy John Kerry and his Chinese counterpart. This setback in curbing climate change brings to light the exciting opportunities for companies that provide equipment to address this pressing issue. Although talks this week didn't result in a major climate agreement, … [Read more...] about The Impasse over Carbon Emissions: A Boost for Clean-Tech Companies
Caribou Biosciences Receives $25 Million Investment from Pfizer
Shares of Caribou Biosciences, a clinical-stage genome-editing biopharmaceutical company, saw a significant surge in premarket trading following news of a $25 million equity investment from drug giant Pfizer. This investment has been made at a healthy premium and has propelled Caribou's shares up by 36% to $5.56 during premarket trading. Pfizer purchased approximately 4.69 … [Read more...] about Caribou Biosciences Receives $25 Million Investment from Pfizer
